Recor Medical, headquartered in Palo Alto, CA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is an investigational device in Japan, is FDA approved in the United States, and bears the CE mark. Recor has reported positive outcomes in three independent, randomized, sham-controlled studies of the Paradise System in patients with mild-to-moderate and resistant hypertension. In addition, Recor has begun the Global Paradise System (“GPS”) Registry in the EU, with plans to expand globally.

Website: http://www.recormedical.com/

Social:
 (6) Recor Medical: Ihr Unternehmen | LinkedIn

 Recor Medical - Ultrasound Renal Denervation - YouTube

 Latest on Ultrasound Renal Denervation | Radcliffe Cardiology
                   

 Documents annexes : http://venues-webservices.gl-events.com/logo/MKT-0140(B) Paradise HCP Brochure_FRENCH.pdf

                                                  http://venues-webservices.gl-events.com/logo/MKT-0140(B) Paradise HCP Brochure-English_Digital.pdf

                                                  http://venues-webservices.gl-events.com/logo/MKT-0179(A) Paradise uRDN Clinical Brochure_Digital.pdf